Provided by Tiger Trade Technology Pte. Ltd.

Biogen

229.41
+3.701.64%
Pre-market: 232.002.59+1.13%08:41 EDT
Volume:1.46M
Turnover:339.82M
Market Cap:33.87B
PE:40.75
High:238.24
Open:233.98
Low:229.00
Close:225.71
52wk High:238.24
52wk Low:138.00
Shares:147.64M
Float Shares:147.31M
Volume Ratio:1.35
T/O Rate:0.99%
Dividend:- -
Dividend Rate:- -
EPS(TTM):5.63
EPS(LYR):8.79
ROE:4.58%
ROA:5.21%
PB:1.80
PE(LYR):26.10

Loading ...

Biogen Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
15 hours ago

Sector Update: Healthcare Stocks Rise Late Afternoon

MT Newswires Live
·
16 hours ago

Biogen Shares Rise After JPMorgan Upgrade

MT Newswires Live
·
18 hours ago

Biogen on Track for Highest Close Since July 2024

Dow Jones
·
19 hours ago

S&P 500 Top and Bottom Performing Stocks at About 12:00 P.m. EDT

Reuters
·
20 hours ago

US Stocks on the MOVE-Salesforce, Brown & Brown, IonQ, Harmony Biosciences

Reuters
·
Yesterday

Biogen price target raised to $220 from $208 at BMO Capital

TIPRANKS
·
Yesterday

Biogen Gets JPMorgan Upgrade Ahead of Key Data Readouts

Dow Jones
·
Yesterday

Biogen Price Target Raised to $300.00/Share from $210.00 by JP Morgan

Dow Jones
·
Yesterday

Biogen : Bmo Raises Target Price to $220 from $208

THOMSON REUTERS
·
Yesterday

U.s. Stocks on the Move-GoDaddy, Biogen, Iren

Reuters
·
Yesterday

BMO Capital Adjusts Price Target on Biogen to $220 From $208

MT Newswires Live
·
Yesterday

J.P. Morgan Upgrades Biogen to 'overweight', Shares Rise

Reuters
·
Yesterday

Biogen Shares Rise 2.1% Premarket After JP Morgan Raises to Overweight from Neutral

THOMSON REUTERS
·
Yesterday

Biogen : JP Morgan Raises to Overweight from Neutral; Raises Target Price to $300 from $210

THOMSON REUTERS
·
Yesterday

U.S. Stocks on the MOVE -VF Corp, Biogen, AbbVie

Reuters
·
Oct 10

UBS Lifts Biogen PT on Late-Stage Pipeline Catalysts; Shares Rise

Reuters
·
Oct 10

Biogen Price Target Raised to $270.00/Share from $240.00 by UBS

Dow Jones
·
Oct 09

Pharma Stocks Jump With Novavax up 12%, Moderna up 6%

Tiger Newspress
·
Oct 09

UBS Adjusts Price Target on Biogen to $270 From $240, Maintains Buy Rating

MT Newswires Live
·
Oct 09